Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L34 pseudogene 21 (RPL34P21) is a non-functional genomic sequence with significant similarity to the functional *RPL34* gene, which encodes a component of the cytoplasmic 60S ribosomal subunit[5][10]. As a processed pseudogene, RPL34P21 does not produce a protein, is not known to have a biological function, and is not recognized as a drug or therapeutic target. Pseudogenes like RPL34P21 are common for ribosomal protein genes, and their biological roles, if any, are usually limited and speculative; some studies suggest possible noncoding RNA roles, but there is no evidence of this for RPL34P21 specifically[2].\n\nKey distinction:\nDo not confuse RPL34P21 (a pseudogene, not a protein) with its parent gene *RPL34*, which produces ribosomal protein L34, a structural ribosome component sometimes implicated in cancer and cell proliferation[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L34 pseudogene 21 (RPL34P21).